{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T01:19:03Z","timestamp":1747358343988},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T00:00:00Z","timestamp":1413331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s40272-014-0093-1","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T11:19:15Z","timestamp":1413285555000},"page":"523-529","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Optimized Antimicrobial Dosing Strategies: A Survey of Pediatric Hospitals"],"prefix":"10.1007","volume":"16","author":[{"given":"Chad A.","family":"Knoderer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen R.","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elaine G.","family":"Cox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,15]]},"reference":[{"key":"93_CR1","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1128\/AAC.00622-08","volume":"52","author":"X Qin","year":"2008","unstructured":"Qin X, Zerr DM, Weissman SJ, Englund JA, et al. Prevalence and mechanisms of broad-spectrum beta-lactam resistance in Enterobacteriaceae: a children\u2019s hospital experience. Antimicrob Agents Chemother. 2008;52:3909\u201314. doi: 10.1128\/AAC.00622-08 .","journal-title":"Antimicrob Agents Chemother"},{"key":"93_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/pbc.22926","volume":"57","author":"HA El-Mahallawy","year":"2011","unstructured":"El-Mahallawy HA, El-Wakil M, Moneer MM, Shalaby L. Antibiotic resistance is associated with longer bacteremic episodes and worse outcomes in febrile neutropenic children with cancer. Pediatr Blood Cancer. 2011;57:283\u20138. doi: 10.1002\/pbc.22926 .","journal-title":"Pediatr Blood Cancer"},{"key":"93_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijantimicag.2013.11.006","volume":"43","author":"KJ Downes","year":"2014","unstructured":"Downes KJ, Hahn A, Wiles J, Courter JD, Vinks AA. Dose optimization of antibiotics in children: application of pharmacokinetics\/pharmacodynamics in paediatrics. Int J Antimicrob Agents. 2014;43:223\u201330. doi: 10.1016\/j.ijantimicag.2013.11.006 .","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"93_CR4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/510590","volume":"44","author":"TP Lodise Jr","year":"2007","unstructured":"Lodise TP Jr, Lomaestro B, Drusano GL. Piperacillin-tazobactam for Pseudomonas aeruginosa infection: clinical implications of an extended-infusion dosing strategy. Clin Infect Dis. 2007;44(3):357\u201363.","journal-title":"Clin Infect Dis"},{"key":"93_CR5","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1592\/phco.26.9.1320","volume":"26","author":"TP Lodise Jr","year":"2006","unstructured":"Lodise TP Jr, Lomaestro B, Drusano GL. Application of antimicrobial pharmacodynamics concepts into clinical practice: focus on \u03b2-lactam antibiotics. Pharmacotherapy. 2006;26:1320\u201332.","journal-title":"Pharmacotherapy"},{"key":"93_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cid\/cis857","volume":"56","author":"ME Falagas","year":"2013","unstructured":"Falagas ME, Tansarli GS, Ikawa K, Vardakas KZ. Clinical outcomes with extended or continuous versus short-term intravenous infusion of carbapenems and piperacillin\/tazobactam: a systematic review and meta-analysis. Clin Infect Dis. 2013;56:272\u201382. doi: 10.1093\/cid\/cis857 .","journal-title":"Clin Infect Dis"},{"key":"93_CR7","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/AAC.39.3.650","volume":"39","author":"DP Nicolau","year":"1995","unstructured":"Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with an once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob Agents Chemother. 1995;39:650\u20135.","journal-title":"Antimicrob Agents Chemother"},{"key":"93_CR8","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1542\/peds.114.1.e111","volume":"114","author":"DG Contopoulos-Ioannidis","year":"2004","unstructured":"Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JPA. Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics. 2004;114:e111. doi: 10.1542\/peds.114.1.e111 .","journal-title":"Pediatrics"},{"key":"93_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1592\/phco.23.1.44.31924","volume":"23","author":"CA Knoderer","year":"2003","unstructured":"Knoderer CA, Everett JA, Buss WF. Clinical issues surrounding once-daily aminoglycoside dosing in children. Pharmacotherapy. 2003;23:44\u201356.","journal-title":"Pharmacotherapy"},{"key":"93_CR10","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.clinthera.2012.05.005","volume":"34","author":"KR Nichols","year":"2012","unstructured":"Nichols KR, Knoderer CA, Cox EG, Kays MB. System-wide implementation of the use of an extended-infusion piperacillin\/tazobactam dosing strategy: feasibility of utilization from a children\u2019s hospital perspective. Clin Ther. 2012;34:1459\u201365. doi: 10.1016\/j.clinthera.2012.05.005 .","journal-title":"Clin Ther"},{"key":"93_CR11","first-page":"49","volume":"15","author":"CA Knoderer","year":"2010","unstructured":"Knoderer CA, Morris JL, Cox EG. Continuous infusion of nafcillin for sternal osteomyelitis in an infant following cardiac surgery. J Pediatr Pharmacol Ther. 2010;15:49\u201354.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"93_CR12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1345\/aph.1R216","volume":"46","author":"MC Walker","year":"2012","unstructured":"Walker MC, Lam WM, Manasco KB. Continuous and extended-infusions of \u03b2-lactam antibiotics in the pediatric population. Ann Pharmacother. 2012;46:1537\u201346. doi: 10.1345\/aph.1R216 .","journal-title":"Ann Pharmacother"},{"key":"93_CR13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/pbc.22051","volume":"53","author":"JD Courter","year":"2009","unstructured":"Courter JD, Kuti JL, Girotto JE, Nicolau DP. Optimizing bactericidal exposure for \u03b2-lactams using prolonged and continuous infusions in the pediatric population. Pediatr Blood Cancer. 2009;53:379\u201385. doi: 10.1002\/pbc.22051 .","journal-title":"Pediatr Blood Cancer"},{"key":"93_CR14","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/INF.0b013e3182a743c7","volume":"33","author":"JJ Cies","year":"2014","unstructured":"Cies JJ, Shankar V, Schlichting C, Kuti JL. Population pharmacokinetics of piperacillin\/tazobactam in critically ill chidren. Pediatr Infec Dis J. 2014;33:168\u201373. doi: 10.1097\/INF.0b013e3182a743c7 .","journal-title":"Pediatr Infec Dis J"},{"key":"93_CR15","first-page":"262","volume":"16","author":"WA Prescott Jr","year":"2011","unstructured":"Prescott WA Jr. National survey of extended-interval aminoglycoside dosing in pediatric cystic fibrosis pulmonary exacerbations. J Pediatr Pharmacol Ther. 2011;16:262\u20139. doi: 10.5863\/1551-6776-16.4.262 .","journal-title":"J Pediatr Pharmacol Ther"},{"key":"93_CR16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1086\/313692","volume":"30","author":"SK Chuck","year":"2000","unstructured":"Chuck SK, Raber SR, Rodvold KA, Areff D. National survey of extended-interval aminoglycoside dosing. Clin Infect Dis. 2000;30:433\u20139. doi: 10.1086\/313692 .","journal-title":"Clin Infect Dis"},{"key":"93_CR17","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/cid\/cis545","volume":"55","author":"PD Tamma","year":"2012","unstructured":"Tamma PD, Turnbull AE, Milstone AM, Hsu AJ, Carroll KC, Cosgrove SE. Does the piperacillin minimum inhibitory concentration for Pseudomonas aeruginosa influence clinical outcomes of children with pseudomonal bacteremia? Clin Infect Dis. 2012;55:799\u2013806. doi: 10.1093\/cid\/cis545 .","journal-title":"Clin Infect Dis"},{"key":"93_CR18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/INF.0b013e3181ef2507","volume":"29","author":"JG Newland","year":"2010","unstructured":"Newland JG, Hersh AL. Purpose and design of antimicrobial stewardship programs in pediatrics. Pediatr Infect Dis J. 2010;29:862\u20133. doi: 10.1097\/INF.0b013e3181ef2507 .","journal-title":"Pediatr Infect Dis J"},{"key":"93_CR19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"TH Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an hospital program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159\u201377.","journal-title":"Clin Infect Dis"},{"key":"93_CR20","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology\u2014drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157\u201367.","journal-title":"N Engl J Med"},{"key":"93_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/516284","volume":"26","author":"WA Craig","year":"1998","unstructured":"Craig WA. Pharmacokinetic\/pharmacodynamic parameters: rationale for antimicrobial dosing of mice and men. Clin Infect Dis. 1998;26:1\u201310.","journal-title":"Clin Infect Dis."},{"key":"93_CR22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00148581-200709060-00003","volume":"9","author":"CM Rubino","year":"2007","unstructured":"Rubino CM, Bradley JS. Optimizing therapy with antimicrobial agents: use of pharmacokinetic-pharmacodynamic principles in pediatrics. Paediatr Drugs. 2007;9:361\u20139.","journal-title":"Paediatr Drugs"},{"key":"93_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/PCC.0b013e3181b80693","volume":"11","author":"SA Lopez","year":"2010","unstructured":"Lopez SA, Mulla H, Durward A, Tibby SM. Extended-interval gentamicin: population pharmacokinetics in pediatric critical illness. Pediatr Crit Care Med. 2010;11:267\u201374. doi: 10.1097\/PCC.0b013e3181b80693 .","journal-title":"Pediatr Crit Care Med"},{"key":"93_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200666010-00001","volume":"66","author":"AC DeRyke","year":"2006","unstructured":"DeRyke AC, Lee SY, Kuti JL, Nicolau DP. Optimising dosing strategies of antimicrobials utilising pharmacodynamic principles: impact on the development of resistance. Drugs. 2006;66:1\u201314.","journal-title":"Drugs."},{"issue":"2","key":"93_CR25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/j.1875-9114.1995.tb04354.x","volume":"15","author":"GT Schumock","year":"1995","unstructured":"Schumock GT, Raber SR, Crawford SY, Naderer OJ, Rodvold KA. National survey of once-daily dosing of aminoglycoside antibiotics. Pharmacotherapy. 1995;15(2):201\u20139.","journal-title":"Pharmacotherapy"},{"key":"93_CR26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2165\/00128072-200204070-00005","volume":"4","author":"DM Kraus","year":"2002","unstructured":"Kraus DM, Pai MP, Rodvold KA. Efficacy and tolerability of extended-interval aminoglycoside administration in pediatric patients. Paediatr Drugs. 2002;4:468\u201384.","journal-title":"Paediatr Drugs"},{"key":"93_CR27","doi-asserted-by":"crossref","first-page":"F294","DOI":"10.1136\/adc.2004.056317","volume":"90","author":"E Nestaas","year":"2005","unstructured":"Nestaas E, Bangstad HJ, Sandvik L, Wathne KO. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2005;90:F294\u2013300. doi: 10.1136\/adc.2004.056317 .","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"suppl A","key":"93_CR28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/15.suppl_A.37","volume":"15","author":"BS Vogelman","year":"1985","unstructured":"Vogelman BS, Craig WA. Postantibiotic effects. J Antimicrob Chemother. 1985;15(suppl A):37\u201346.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"93_CR29","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1128\/AAC.31.7.1061","volume":"31","author":"P Auwera Van der","year":"1987","unstructured":"Van der Auwera P, Klastersky J. Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin. Antimicrob Agents Chemother. 1987;31(7):1061\u20131068.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40272-014-0093-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-014-0093-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T22:02:14Z","timestamp":1717452134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40272-014-0093-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,15]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["93"],"URL":"https:\/\/doi.org\/10.1007\/s40272-014-0093-1","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,15]]}}}